Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

The United Kingdom's Medicines and Healthcare Products Regulatory Agency strengthened its warnings on GLP-1 receptor agonists ...

Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

The health number that matters more than cholesterol for stroke risk is Apolipoprotein B (ApoB), which is a blood marker that ...

Arguably, the most important thing you can have in this life is your health. No matter how much money you have or resources ...

Jay Bhattacharya, the N.I.H. director, says authorities broke the public’s trust in the Covid era. Now it’s up to outsiders ...

Many people's worst nightmare is being diagnosed with a terminal illness. It happens when you least expect it, and suddenly, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Memantine, a cheaply available drug used for decades to treat Alzheimer's, may help prevent sickle cell crises, especially in ...

The Accelerating Pace Of Technological Advancement It feels like every week there’s some new gadget or software ...